No Data
No Data
Third quarter IPO report: Hong Kong stock market once again witnessed billion-dollar projects, the number and amount of Chinese enterprise IPOs rebounded year-on-year
In Q3 2024, a total of 52 Chinese companies successfully IPO'd on A-shares, Hong Kong stocks, and US stocks. The number of IPOs decreased by 52.29% year-on-year, but increased by 18.18% compared to the previous period. In the first three quarters, the number of IPOs of Chinese companies globally decreased by 54.98% year-on-year.
Valuation of nearly 70% off the line dropped before the lifting period, but Shenghe Bio-B (02898) became the "18A tragedy".
November 24th is the day when the company's cornerstone lock-up period ends. Currently, there are 36 days until the lock-up period ends, and at this time, the company's only IPO cornerstone, Nanjing Jingkai Future, is clearly deeply trapped.
Sudden Movement Spotlight | Biomedical Class B shares rose in the afternoon, LKYG-B up 30%, institutions bullish on sector further recovery space
Biomedical Class B shares rose in the afternoon, as of the time of publication, Lai Kai Medicine-B rose by 27.88%, to 7.89 Hong Kong dollars; YimingAngke-B rose by 17.91%, to 5.86 Hong Kong dollars; Yasheng Medicine-B rose by 5.74%, to 46.95 Hong Kong dollars.
SUNHO BIO-B: Interim Report 2024
The interim loss of Shenghe Bio (02898.HK) narrowed to 36.08 million RMB.
Shenghe Bioscience - B (02898.HK) announced its interim performance for the six months ending in June. Other income recorded RMB 1.78 million (same below), a 70.4% decrease from the previous year. The loss attributable to owners narrowed from RMB 61.49 million in the same period last year to RMB 36.08 million, with a loss per share of 34 cents. No interim dividend will be distributed.
Shenghe Life Sciences-B (02898) released its interim performance, with a loss of 36.077 million yuan during the period, a year-on-year narrowing of 41.33%.
Shenghe Bio-B (02898) announced its interim performance for the six months ended June 30, 2024. During this period, the group...
No Data
No Data